Discontinued — last reported Q4 '25
Retained Earnings
EquityEli Lilly Retained Earnings increased by 10.0% to $24.47B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 80.7%, from $13.55B to $24.47B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 25.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Consistent growth indicates sustained profitability and the ability to self-fund growth, while a decrease may result from net losses or aggressive dividend/buyback programs.
Detailed definition
The cumulative amount of net income that has been reinvested in the business rather than distributed to shareholders as...
Peer comparison
High-growth tech companies may have lower retained earnings if they are younger, while established giants show massive cumulative balances.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.53B | $9.64B | $8.96B | $9.37B | $8.56B | $10.01B | $10.04B | $10.64B | $10.37B | $10.31B | $10.31B | $12.55B | $13.18B | $13.63B | $13.55B | $15.10B | $17.38B | $22.25B | $24.47B |
| QoQ Change | — | +13.0% | -7.1% | +4.6% | -8.7% | +17.0% | +0.4% | +5.9% | -2.5% | -0.6% | +0.0% | +21.7% | +5.0% | +3.4% | -0.6% | +11.5% | +15.1% | +28.1% | +10.0% |
| YoY Change | — | — | — | — | +0.3% | +3.8% | +12.1% | +13.6% | +21.2% | +3.0% | +2.7% | +18.0% | +27.1% | +32.2% | +31.3% | +20.3% | +31.9% | +63.3% | +80.7% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Eli Lilly's retained earnings?
- Eli Lilly (LLY) reported retained earnings of $24.47B in Q4 2025.
- How has Eli Lilly's retained earnings changed year-over-year?
- Eli Lilly's retained earnings increased by 80.7% year-over-year, from $13.55B to $24.47B.
- What is the long-term trend for Eli Lilly's retained earnings?
- Over 5 years (2020 to 2025), Eli Lilly's retained earnings has grown at a 25.6% compound annual growth rate (CAGR), from $7.83B to $24.47B.
- What does retained earnings mean?
- The total profits the company has kept and reinvested since it started, after paying out any dividends.